Zhang Hai-Tian, Lu Yun-Fei, Zeng Jian, Lin Jian, Liao Qing-Hua, Wan Fu-Qiang
Department of Gastrointestinal and Glands Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China.
Zhonghua Wai Ke Za Zhi. 2007 Apr 1;45(7):480-2.
To detect the mutations of BRCA1 and BRCA2 in sporadic breast cancer and study the relationship between BRCA1 and BRCA2 mutations and breast cancer.
Breast cancer tissues of 144 patients and breast tissues of 30 cases of healthy people who were treated from December 2000 to September 2005 were studied. DNA was extracted by the phenol-chloroform method. Fragments of exon 2, exon 3, exon 5, exon 6, exon 7, exon 8, exon 9, exon 10, exon 11, exon 12, exon 13, exon 14, exon 15, exon 16, exon 17, exon 18, exon 19, exon 20, exon 21, exon 22, exon 23 and exon 24 in the BRCA1 gene and exon 10 and exon 14 in the BRCA2 gene were amplified by polymerase chain reaction. Mutation screening was performed by single-strand conformation polymorphism analysis and alterations were confirmed by DNA sequencing.
A total of 20 single nucleotide changes in BRCA1 were detected in the 144 cases of breast cancer patients. The total mutation rate was 13.9% and missense mutation rate was 11.1%. No mutation was detected in the BRCA2 and controls.
Mutations in BRCA1 may play an important role in evaluation of sick risk, earlier diagnosis and gene therapy of breast cancer in southern Chinese populations.
检测散发性乳腺癌中BRCA1和BRCA2基因的突变情况,研究BRCA1和BRCA2基因突变与乳腺癌的关系。
对2000年12月至2005年9月收治的144例乳腺癌患者的癌组织及30例健康人的乳腺组织进行研究。采用酚-氯仿法提取DNA。应用聚合酶链反应扩增BRCA1基因的第2、3、5、6、7、8、9、10、11、12、13、14、15、16、17、18、19、20、21、22、23、24外显子以及BRCA2基因的第10和14外显子片段。通过单链构象多态性分析进行突变筛查,并经DNA测序确认变异情况。
144例乳腺癌患者中,共检测到BRCA1基因20个单核苷酸改变。总突变率为13.9%,错义突变率为11.1%。BRCA2基因及对照组未检测到突变。
BRCA1基因突变可能在华南地区人群乳腺癌患病风险评估、早期诊断及基因治疗中发挥重要作用。